Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07932262
PHASE1/PHASE2

An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1

Sponsor: University Hospital Tuebingen

View on ClinicalTrials.gov

Summary

An open-label phase I/II, single-center, interventional single-arm basket trial of UKT-CART19.1 in patients with relapsed/refractory autoimmune diseases

Official title: An Open-label Phase I/II, Single-center, Interventional Singlearm Basket Trial of UKT-CART19.1 in Patients With Relapsed/Refractory Autoimmune Diseases

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2027-01

Completion Date

2028-09

Last Updated

2026-11-12

Healthy Volunteers

No

Interventions

BIOLOGICAL

CAR-T cells targeting CD19

Single dose containing 1.0×10\^6CAR+ cells per kg body weight

Locations (1)

University Hospital , Department of Internal Medicine II

Tübingen, Baden-Wurttemberg, Germany